PARD (Poniard Pharmaceuticals) Gross Margin %: 0.00% (As of Sep. 2011)

What is Poniard Pharmaceuticals Gross Margin %?

Poniard Pharmaceuticals PARD Gross Margin % is 0.00% as of Sep. 2011.

Gross Margin % is calculated as gross profit divided by its revenue. Poniard Pharmaceuticals's Gross Profit for the three months ended in Sep. 2011 was $0.00 Mil. Poniard Pharmaceuticals's Revenue for the three months ended in Sep. 2011 was $0.00 Mil. Therefore, Poniard Pharmaceuticals's Gross Margin % for the quarter that ended in Sep. 2011 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.

The historical rank and industry rank for Poniard Pharmaceuticals's Gross Margin % or its related term are showing as below:

PARD's Gross Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: 60.94
* Ranked among companies with meaningful Gross Margin % only.

Poniard Pharmaceuticals had a gross margin of N/A% for the quarter that ended in Sep. 2011 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Poniard Pharmaceuticals was 0.00% per year.

Poniard Pharmaceuticals (OTCPK:PARD) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Poniard Pharmaceuticals had a gross margin of N/A% for the quarter that ended in Sep. 2011 => No sustainable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Poniard Pharmaceuticals Gross Margin % Related Terms

Poniard Pharmaceuticals Gross Margin % Historical Data

* Premium members only.

The historical data trend for Poniard Pharmaceuticals's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poniard Pharmaceuticals Gross Margin % Chart

Poniard Pharmaceuticals Annual Data

Trend

Dec01

Dec02

Dec03

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Gross Margin %

Get a 7-Day Free Trial

0.00

Poniard Pharmaceuticals Quarterly Data
	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11
Gross Margin %	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

PARD vs OBMP, NSPX, ATRX: Gross Margin % Comparison

For the Biotechnology subindustry, Poniard Pharmaceuticals's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Poniard Pharmaceuticals Gross Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Poniard Pharmaceuticals's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Poniard Pharmaceuticals's Gross Margin % falls into.

Save Embed

Poniard Pharmaceuticals Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Poniard Pharmaceuticals's Gross Margin for the fiscal year that ended in Dec. 2010 is calculated as

Gross Margin % (A: Dec. 2010 )	=	Gross Profit (A: Dec. 2010 )	/	Revenue (A: Dec. 2010 )
	=	0	/	0
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(0 - 0)	/	0
	=	N/A %

Poniard Pharmaceuticals's Gross Margin for the quarter that ended in Sep. 2011 is calculated as

Gross Margin % (Q: Sep. 2011 )	=	Gross Profit (Q: Sep. 2011 )	/	Revenue (Q: Sep. 2011 )
	=	0	/	0
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(0 - 0)	/	0
	=	N/A %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Margin % →

What does a Gross Margin % of 0.00% mean?

Poniard Pharmaceuticals (PARD) has a Gross Margin % of 0.00% as of Sep. 2011. Gross margin is the ratio of total gross profit to net sales. View historical data on Poniard Pharmaceuticals and its competitors.

Is Poniard Pharmaceuticals' Gross Margin % too high?

Poniard Pharmaceuticals' current Gross Margin % is 0.00%.

How does Poniard Pharmaceuticals' Gross Margin % compare to OBMP and NSPX?

Poniard Pharmaceuticals' Gross Margin % of 0.00% can be compared against companies in the Biotechnology industry. The industry median Gross Margin % is 60.94. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Gross Margin % for a Biotechnology company?

The median Gross Margin % among Biotechnology companies is 60.94, based on 738 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Gross Margin % mean?

A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Poniard Pharmaceuticals and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Poniard Pharmaceuticals's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Poniard Pharmaceuticals stock overvalued right now?

Poniard Pharmaceuticals (PARD) has a current Gross Margin % of 0.00%. The current Gross Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Gross Margin % calculated?

Gross Margin % is calculated from a company's financial statements. For Poniard Pharmaceuticals (PARD), the current Gross Margin % is 0.00% as of Sep. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Poniard Pharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies BOM:506365 OBMP NSPX BOM:532041 ATRX PPCB WAR:PFM RSPI TSXV:MFS BOM:542765 HSTC CAPS ATMS AKAOQ BRTX TSXV:PBS BOM:532871 APOP TSXV:APC ONTX

Address 300 Elliott Avenue West, Suite 530, Seattle, CA, USA, 98119

Website http://www.poniard.com

Poniard Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of cancer therapeutics. Its product candidate is picoplatin, a new generation platinum-based cancer therapy.